Home > Products > CD133 & EGFR
> Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (scFv4-Ig)
Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (scFv4-Ig) (CAT#: FVTIG-031)
Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (scFv4-Ig) is an appended IgG format, which includes four scFv moieties at the N-termini of the constant regions. It is a bivalent homodimer, in which one anti-CD133 scFv is fused to the CH1 domain of a heavy chain and another anti-EGFR scFv to the CL domain of a light chain, or vice versa. The resulting leads to 2+2 antigen-binding valency. This BsAb can target brain tumor stem cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors
There are currently no customer reviews or questions for Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (scFv4-Ig) (FVTIG-031). Click the button below to contact us or submit your feedback about this product.